Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature-Reference-Cited by-同舟云学术

Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature

Published:2012-07-31 Issue:1 Volume:159 Page:39-49
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Guirguis Hany R.¹,Cheung Matthew C.¹,Mahrous Mervat²,Piliotis Eugenia¹,Berinstein Neil¹,Imrie Kevin R.¹,Zhang Liying¹,Buckstein Rena¹

Affiliation:

1. Hematology/Oncology; Sunnybrook Odette Cancer Center; University of Toronto; Toronto; ON; Canada

2. Clinical Oncology; Minia University Hospital; El Minia; Egypt

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2012.09247.x/fullpdf

Reference30 articles.

1. Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma;Abramson;Cancer,2010

2. Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 - the Southwest Oncology Group;Bernstein;Journal of Clinical Oncology,2009

3. Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma;Besien;Blood,1998

4. Incidence and risk factors of central nervous system recurrence in aggressive lymphoma - a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL);Boehme;Annals of Oncology,2007

5. CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL);Boehme;Blood,2009

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent updates on central nervous system prophylaxis in patients with high-risk diffuse large B-cell lymphoma;Experimental Hematology & Oncology;2024-01-03

2. High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma;Journal of Clinical Oncology;2023-12-10

3. Comparison of the Effect of Chemoradiotherapy and Chemotherapy on the Survival of Patients with Primary Diffuse Large B-Cell Lymphoma of the Spine: A SEER-Based Study;World Neurosurgery;2023-07

4. Application of the Central Nervous System International Prognostic Index (CNS-IPI) score in daily practice: a retrospective analysis apart from the clinical trial at two centers in Brazil;Hematology, Transfusion and Cell Therapy;2023-03